Live Breaking News & Updates on System Discovery Platform|Page 1

Stay updated with breaking news from System discovery platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Biomea Fusion Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights

Expanded clinical development footprint of BMF-219, the company’s lead investigational, orally administered, covalent menin inhibitor, to eight liquid and solid tumor indications and type 2. | March 28, 2023 ....

Thomas Butler , Biomea Fusion Inc , Exchange Commission , Development Rd Expenses , Securities Exchange , Company Nasdaq , Recent Clinical , Regulatory Highlights , Genetically Defined Liquid Tumors , Mutant Solid Tumors , Acute Leukemias , Investigational New Drug , System Discovery Platform , Cash Equivalents , Restricted Cash , Securities Act , Securities Exchange Act , Exchange Act , Biomea Fusion , Nc Stock Exchange , Press Release , Ype Bmea Us09077a1060 ,

Biomea Fusion to Present at 41st Annual J.P. Morgan Healthcare Conference and Highlight 2023 Corporate Milestones

Biomea Fusion to Present at 41st Annual J.P. Morgan Healthcare Conference and Highlight 2023 Corporate Milestones
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Thomas Butler , Sasha Blaug , Exchange Commission , Team Fusion , Corporate Development , Securities Exchange , Biomea Fusion Inc , Biomea Fusion , Chief Executive Officer , Healthcare Conference , Anticipated Milestone , Anticipated Milestones , System Discovery Platform , Securities Act , Securities Exchange Act , Exchange Act , Vice President ,